<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03197909</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL17_0210</org_study_id>
    <nct_id>NCT03197909</nct_id>
  </id_info>
  <brief_title>Involvement of Plasmatic Factors in the Peripheral Muscle Dysfunction of COPD Patients - In Vitro Study</brief_title>
  <official_title>Involvement of Plasmatic Factors in the Peripheral Muscle Dysfunction of COPD Patients - In Vitro Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic Obstructive Pulmonary Patients is a defined by persistent airflow limitation that is
      usually progressive and associated with an enhanced chronic inflammatory response in the
      airways and the lung to noxious particles or gases. It is associated with an atrophy of the
      skeletal muscle that impairs the patient's prognosis. The biological mechanisms of this
      muscle atrophy have not been elucidated, and the &quot;spill-over theory&quot; has recently emerged.
      Indeed, in COPD patients, the pulmonary inflammation is associated with a systemic low-grade
      inflammation, and the increased pro-inflamatory molelcules in the blood - which constitute
      the cellular micro-environement of the muscle fibre - could activate the mechanisms of the
      cell atrophy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 6, 2017</start_date>
  <completion_date type="Anticipated">January 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Myotube diameter of in vitro cultured myotubes</measure>
    <time_frame>6 days</time_frame>
    <description>Myotube diameter of in vitro cultured myotubes from healthy subjects, exposed to the serum of healthy controls and COPD patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Expression and translation of markers of</measure>
    <time_frame>6 days</time_frame>
    <description>Expression and translation of markers of anabolic and catabolic pathways</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Level of pro-Inflamatory markers</measure>
    <time_frame>6 days</time_frame>
    <description>Level of pro-Inflamatory markers in the serum</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Chronic Obstructive Pulmonary</condition>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <description>Determination of pro-inflammatory plasma factors at Healthy subjects aged from 35 to 85 years old</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD patients</arm_group_label>
    <description>Determination of pro-inflammatory plasma factors at COPD patients aged from 35 to 85 years old</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Determination of pro-inflammatory plasma factors</intervention_name>
    <description>Determination of pro-inflammatory plasma factors at COPD patients aged from 35 to 85 years old and Healthy subjects aged from 35 to 85 years old</description>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_label>COPD patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Chronic Obstructive Pulmonary Patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        35 to 85 years old

          -  COPD patients: association of symtoms (breathlessness, cough, sputum) and chronic
             exposure to inhalated risk factors (like tobacco smoke) and a FEV1/VC ratio &lt;70%
             assessed by a spirometry

          -  Healthy subjects: A sedentariness assessed by a Voorrips score &lt;9.4 and/or a report of
             &lt;150 min/week of moderate-to-vigorous physical activity

        Exclusion Criteria:

          -  A recent COPD exacerbation (&lt; 4weeks)

          -  The decompensation of a comorbidity

          -  An antioxidant supplementation or medication

          -  A long-term systemic corticosteroid medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maurice HAYOT, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maurice HAYOT, MD, PhD</last_name>
    <phone>467335908</phone>
    <phone_ext>33</phone_ext>
    <email>m-hayot@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34290</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maurice HAYOT, MD, phD</last_name>
      <phone>467335908</phone>
      <phone_ext>33</phone_ext>
      <email>m-hayot@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2017</study_first_submitted>
  <study_first_submitted_qc>June 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2017</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD (Chronic Obstructive Pulmonary Patients)</keyword>
  <keyword>Atrophy</keyword>
  <keyword>cell cultur</keyword>
  <keyword>systemic inflammation</keyword>
  <keyword>Catabolism</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

